An interventional study of On the Move group exercise in Mobility Limitation, sponsored by University of Pittsburgh. Completed at 1 site in United States. Open to participants aged 60 Years and older, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-11-20.
Sponsored by University of Pittsburgh · Not applicable, Interventional, and Treatment
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
Among 126 studies in Mobility Limitation with a site in United States — 31 open to participants now, 35 under way, 3 of them phase 3. Mobility Limitation · United States.
Among the 126 studies in Mobility Limitation with a site in United States, this one is the 4th largest by enrollment of the 116 interventional ones that give a count, is one of 6 that started in 2022, is one of 93 with no phase, and was the 79th registered.
383 studies on the registry are indexed under Mobility Limitation; 106 are open to participants now.
Browse Mobility Limitation studies →31 of the 126 studies in Mobility Limitation with a site in United States are open now. Recruiting first, the newest first:
RxFunction Inc. · Sites in United States
Ages 60+
St. Jude Children's Research Hospital · Sites in United States
Ages 5–20 · Healthy volunteers
Wake Forest University Health Sciences · Sites in United States
Ages 18+
The University of Alabama in Huntsville · Sites in United States
Ages 65+ · Healthy volunteers
University of Florida · Sites in United States
Ages 65–90
A study can be open while its sites in United States have not opened yet or have stopped. Only those recruiting at a site in United States →
Of the 65 Mobility Limitation studies recruiting now, 33 (51%) set no upper age limit and 15 (23%) stop at 75 or younger; 5 take children under 18; 9 take healthy volunteers.
This study: 60 Years and older · all sexes · healthy volunteers too.
The full table on the hub →This tab as a report to print or save as PDF → With an account.
126 studies; the count open now beside each. This study's row is marked.
A study in two phases is counted once above. Listed by phase, each with its combined phases: Phase 1 8 · Phase 2 11 · Phase 3 9
First in 1997; this study’s year is marked. 6 started in 2022.
By drug class, each counting the studies that test any of its medicines:
This study's enrollment of 529 is above the median of 46 across 318 interventional studies indexed under Mobility Limitation.
Median enrollment 40 across the 116 interventional studies, 92 across the 10 observational. Of the 83 that completed or were terminated, 30 (36%) have results posted.
This tab as a report to print or save as PDF → With an account.
11 of 126 have an industry lead sponsor. The 10 most frequent:
University of Pittsburgh is the lead sponsor of 1,422 studies on the registry; 170 are open to participants now.
Of its 9 completed or terminated interventional studies of FDA-regulated products, 4 (44%) have results posted.
University of Pittsburgh has 4 studies filed under Mobility Limitation — fewer than ten, so there is no comparison to draw.
13 of the studies in Mobility Limitation with a site in United States that are under way reach primary completion within a year, 0 of them phase 3. Phase 3 first, then by date:
| Study | Primary completion |
|---|---|
| NCT07125378University of FloridaLiving Independence Through Functional Training | 2026-11-30 |
| NCT05725564Milton S. Hershey Medical CenterTesting Interventions for Mobility Through Exercise (TIME) | 2026-12 |
| NCT06484244Emory UniversityLocomotion Adaptation Deficits in Older Adults With Mild Cognitive Impairment and Alzheimers Disease | 2026-12-31 |
| NCT05661084Hebrew SeniorLifeNon-invasive Brain Stimulation for Cognitive and Motor Dysfunction in Dementia | 2026-12-31 |
| NCT07337317The University of Alabama in HuntsvilleEvaluating Stairway Designs for Individuals With Vision Impairment | 2027-01 |
Add all 13 to your calendar (.ics) → With an account.
Among the 126 studies in Mobility Limitation with a site in United States, from their registry updates:
This tab as a report to print or save as PDF → With an account.
The purpose of this study is to test the effectiveness of On the Move (OTM) in terms of improving mobility among 502 older adults in 44 senior community centers and to evaluate intervention fidelity, including adherence and competence, and the impact of organizational, instructor, and participant level factors on intervention fidelity.
The investigators will conduct a Hybrid I trial, blending effectiveness and implementation research aims to: test the effectiveness of OTM, evaluate intervention fidelity, and determine the extent intervention fidelity moderates intervention effectiveness. The investigators will evaluate the effects of OTM taught by community instructors for improving mobility among 502 older adults in 44 community centers using a cluster randomized design with a delayed intervention control arm. Intervention fidelity will be assessed by instructor self-report (intervention diaries) and observation (fidelity checklist). Organizational, instructor, and participant level factors which may impact fidelity will be assessed via standard instruments, focus groups and interviews.
Specific Aims are as follows:
Aim 1: Establish the effectiveness of OTM on improvements in walking ability and post-intervention persistence of benefits.
Rationale: OTM delivered by research staff is effective. Establishing the effectiveness of OTM delivered by community instructors is necessary before wide-scale implementation.
Hypothesis: Compared to a randomized control group followed for 12 weeks, the OTM group will have greater gains in gait speed (primary outcome) and self-reported mobility at 12 and 24 weeks of follow-up.
Aim 2: Assess intervention fidelity (measures of adherence and competence) and identify the impact of organizational, instructor, and participant level factors on intervention fidelity.
Rationale: To inform future implementation efforts, it is critical to measure intervention fidelity and to identify factors associated with fidelity.
Hypothesis: Organizational, instructor, and participant level factors will impact fidelity. For example, instructors who utilize greater facilitation strategies will have higher fidelity, poor organizational acceptance of the program will be related to lower fidelity, and fewer organizational resources will lead to lower fidelity.
Aim 3: Determine the extent to which intervention fidelity, measured by adherence and competence, moderates the effectiveness of OTM.
Rationale: Intervention fidelity may influence the effectiveness of OTM. Understanding the consequences of differing levels of intervention fidelity on effectiveness will inform future implementation efforts.
Hypothesis: Higher fidelity will be associated with greater mobility gains, and there may be critical fidelity thresholds.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
On the Move group exercise program to improve walking. Delivered twice per week for 12 weeks.
Behavioral: On the Move group exercise
Individuals in this arm will be placed on a wait-list for 12 weeks and will receive no intervention during this time. At the end of the 12 weeks they will receive the On the Move group exercise program. This is a wait-list control group.
Behavioral: On the Move group exercise
The OTM exercise program is a group-based program led by a certified OTM instructor. The frequency and duration of OTM is 50 minutes, twice weekly for 12 weeks for a total of 24 classes. The OTM exercise program is based on principles of motor learning that enhance smooth and automatic movement control. The program contains a warm-up (5 minutes), stepping patterns (15 minutes), walking patterns (15 minutes), strengthening exercises (10 minutes), and cool-down exercises (5 minutes). The warm-up and cool down contain gentle range of motion exercises and stretches for the lower extremities and trunk. Considered essential components, the stepping and walking patterns are progressively more difficult, goal-oriented patterns that promote the timing and coordination of stepping integrated with the phases of the gait cycle.
Change in Gait Speed From Baseline to 12 Weeks
Gait speed is recorded in m/s. It is calculated as 4 meters divided by the time in seconds it takes to walk 4 meters. Faster speeds indicate better mobility. Change is calculated as 12 week gait speed - baseline gait speed. Greater changes (increases) represent more improvement.
Time frame: 12 weeks
Change in Gait Speed From Baseline to 24 Weeks
Gait speed is recorded in m/s. It is calculated as 4 meters divided by the time in seconds it takes to walk 4 meters. Faster speeds indicate better mobility. Change is calculated as 24 week gait speed - baseline gait speed. Greater changes (increases) represent more improvement.
Time frame: 24 weeks
Change in Patient-Reported Outcomes Measurement Information System (PROMIS) Mobility From Baseline to 12 Weeks.
The Patient-Reported Outcomes Measurement Information System - mobility measure is 15 item scale to assess self-reported perceptions of mobility. The score is reported as a standardized T-score based on the U.S. general population. The population mean is 50 and the standard deviation is 10. Typical range of scores is 20 to 80 where scores above 80 and below 20 are rare. A single mobility score is obtained from the short form, with higher scores indicating better mobility. Change calculated as 12 week score minus baseline score.
Time frame: 12 weeks
24 Week Change in Patient-Reported Outcomes Measurement Information System (PROMIS) Mobility
The Patient-Reported Outcomes Measurement Information System - mobility measure is 15 item scale to assess self-reported perceptions of mobility. A single mobility score is obtained from the short form, with higher scores indicating better mobility. Change calculated as 24 week score minus baseline score.
Time frame: 24 weeks
Participant Satisfaction
Participant satisfaction will be assessed using a single item question that includes five items measured on a Likert scale. The question is "how satisfied were you with the On the Move Program?" The Likert items assess degree of satisfaction. We report the number of participants who were satisfied or very satisfied.
Time frame: immediately post intervention
Adherence - Content
We have identified the essential components of OTM. Inclusion of essential components will be determined from exercise class logs. OTM instructors will be required to keep a log of time spent on each program component in each class, for each of the 24 classes. We will review the logs and determine if the essential components (warm-up, walking, stepping patterns, strengthening exercises and cool-down) are included in each of the classes. For each of the classes offered, instructors will be classified as being fully adherent, adherent to core components only, or non-adherent.
Time frame: Throughout the 12 week intervention
Adherence - Dose of Exposure Classes Offered
Dose of exposure classes offered will be quantified as number of classes offered by the community center (0-24). Each community center is required to document when exercise classes are offered. The investigators will obtain this information directly from the community center records. A greater number of classes is better.
Time frame: Throughout the 12 week intervention
Adherence - Dose of Exposure, Weeks of Exercise
Dose of exposure, weeks of exercise will be quantified as the number of weeks the exercise classes are offered (0-12). Each community center is required to document when exercise classes are offered. The investigators will obtain this information directly from the community center records. A greater number of weeks is better.
Time frame: Throughout the 12 week intervention
Adherence - Dose of Exposure, Participant Level.
Dose of exposure at the participant level will be quantified as the number of classes each participant attends, 0-24. The instructor will keep a class log of each session to record attendance. A greater number of classes is better.
Time frame: Throughout the 12 week intervention
Competence - Quality of Delivery
The content experts will use a standardized checklist to document if the instructor is delivering the program with adequate skill. The checklist includes 20 items such as appropriately demonstrating exercises, modifying the exercises as needed, and progressing exercises appropriately. Competence will be quantified by the total number of items present on the checklist; scores will range from 0-20.
Time frame: Throughout the 12 week intervention
Adaptations
Adaptations will be recorded, defined and classified using the Framework for Reporting Adaptations and Modifications-Expanded (FRAME).
Time frame: Throughout the 12 week intervention.
Participants were recruited between June 2022 and March 2025 from individuals receiving services from community-based organizations in southwestern Pennsylvania.
| Milestone | On the Move | On the Move - Delayed |
|---|---|---|
| Started | 272 | 257 |
| 12 week assessment | 229 | 234 |
| 24 week assessment | 215 | 213 |
| Completed | 215 | 213 |
| Not completed | 57 | 44 |
| Withdrew: Death | 1 | 0 |
| Withdrew: Withdrawal by subject | 43 | 36 |
| Withdrew: Lost to follow-up | 13 | 8 |
Gait speed is recorded in m/s. It is calculated as 4 meters divided by the time in seconds it takes to walk 4 meters. Faster speeds indicate better mobility. Change is calculated as 12 week gait speed - baseline gait speed. Greater changes (increases) represent more improvement.
| m/s | On the Move | On the Move - Delayed |
|---|---|---|
| Change in Gait Speed From Baseline to 12 Weeks | 0.07 ± 0.23 | -0.02 ± 0.24 |
Gait speed is recorded in m/s. It is calculated as 4 meters divided by the time in seconds it takes to walk 4 meters. Faster speeds indicate better mobility. Change is calculated as 24 week gait speed - baseline gait speed. Greater changes (increases) represent more improvement.
| m/s | On the Move | On the Move - Delayed |
|---|---|---|
| Change in Gait Speed From Baseline to 24 Weeks | 0.07 (0.05 to 0.10) | -0.02 (-0.04 to 0.01) |
The Patient-Reported Outcomes Measurement Information System - mobility measure is 15 item scale to assess self-reported perceptions of mobility. The score is reported as a standardized T-score based on the U.S. general population. The population mean is 50 and the standard deviation is 10. Typical range of scores is 20 to 80 where scores above 80 and below 20 are rare. A single mobility score is obtained from the short form, with higher scores indicating better mobility. Change calculated as 12 week score minus baseline score.
| score | On the Move | On the Move - Delayed |
|---|---|---|
| Change in Patient-Reported Outcomes Measurement Information System (PROMIS) Mobility From Baseline to 12 Weeks. | 0.7 (-0.1 to 1.6) | -0.7 (-1.5 to 0.1) |
The Patient-Reported Outcomes Measurement Information System - mobility measure is 15 item scale to assess self-reported perceptions of mobility. A single mobility score is obtained from the short form, with higher scores indicating better mobility. Change calculated as 24 week score minus baseline score.
| score | On the Move | On the Move - Delayed |
|---|---|---|
| 24 Week Change in Patient-Reported Outcomes Measurement Information System (PROMIS) Mobility | 0.4 (-0.4 to 1.1) | -0.7 (-1.5 to 0.1) |
Participant satisfaction will be assessed using a single item question that includes five items measured on a Likert scale. The question is "how satisfied were you with the On the Move Program?" The Likert items assess degree of satisfaction. We report the number of participants who were satisfied or very satisfied.
| Participants | On the Move | On the Move - Delayed |
|---|---|---|
| Participant Satisfaction | 210 | 201 |
We have identified the essential components of OTM. Inclusion of essential components will be determined from exercise class logs. OTM instructors will be required to keep a log of time spent on each program component in each class, for each of the 24 classes. We will review the logs and determine if the essential components (warm-up, walking, stepping patterns, strengthening exercises and cool-down) are included in each of the classes. For each of the classes offered, instructors will be classified as being fully adherent, adherent to core components only, or non-adherent.
Results for this outcome have not been posted.
Dose of exposure classes offered will be quantified as number of classes offered by the community center (0-24). Each community center is required to document when exercise classes are offered. The investigators will obtain this information directly from the community center records. A greater number of classes is better.
Results for this outcome have not been posted.
Dose of exposure, weeks of exercise will be quantified as the number of weeks the exercise classes are offered (0-12). Each community center is required to document when exercise classes are offered. The investigators will obtain this information directly from the community center records. A greater number of weeks is better.
Results for this outcome have not been posted.
Dose of exposure at the participant level will be quantified as the number of classes each participant attends, 0-24. The instructor will keep a class log of each session to record attendance. A greater number of classes is better.
Results for this outcome have not been posted.
The content experts will use a standardized checklist to document if the instructor is delivering the program with adequate skill. The checklist includes 20 items such as appropriately demonstrating exercises, modifying the exercises as needed, and progressing exercises appropriately. Competence will be quantified by the total number of items present on the checklist; scores will range from 0-20.
Results for this outcome have not been posted.
Adaptations will be recorded, defined and classified using the Framework for Reporting Adaptations and Modifications-Expanded (FRAME).
Results for this outcome have not been posted.
Collected over From enrollment until the end of the 24 week follow-up. Non-serious events are listed at a 1% frequency threshold.
| Group | Deaths | Serious | Other |
|---|---|---|---|
| On the Move Immediate | 1/272 (0.4%) | 20/272 (7.4%) | 21/272 (7.7%) |
| On the Move Delayed No Exercise | 0/257 (0%) | 11/257 (4.3%) | 7/257 (2.7%) |
| On the Move Delayed - Exercise | 0/257 (0%) | 10/257 (3.9%) | 10/257 (3.9%) |
| Event | On the Move Immediate | On the Move Delayed No Exercise | On the Move Delayed - Exercise |
|---|---|---|---|
| SurgerySurgical and medical procedures | 3/272 | 6/257 | 3/257 |
| FallInjury, poisoning and procedural complications | 5/272 | 2/257 | 1/257 |
| FactureInjury, poisoning and procedural complications | 4/272 | 1/257 | 3/257 |
| Pulmonary EdemaRespiratory, thoracic and mediastinal disorders | 2/272 | 0/257 | 0/257 |
| Stomach PainGastrointestinal disorders | 0/272 | 1/257 | 1/257 |
| Thromboembolic eventVascular disorders | 0/272 | 0/257 | 1/257 |
| Upper respiratory infectionInfections and infestations | 0/272 | 0/257 | 1/257 |
| cardiac arrestCardiac disorders | 0/272 | 1/257 | 0/257 |
| Heart FailureCardiac disorders | 1/272 | 0/257 | 0/257 |
| PenumothoraxRespiratory, thoracic and mediastinal disorders | 1/272 | 0/257 | 0/257 |
| Event | On the Move Immediate | On the Move Delayed No Exercise | On the Move Delayed - Exercise |
|---|---|---|---|
| FallInjury, poisoning and procedural complications | 10/272 | 3/257 | 1/257 |
| FractureInjury, poisoning and procedural complications | 6/272 | 1/257 | 5/257 |
| Pain in extremityMusculoskeletal and connective tissue disorders | 5/272 | 3/257 | 4/257 |
| Age, Continuous(years) | On the Move | On the Move - Delayed | Total |
|---|---|---|---|
| Mean | 77.3 ± 7.5 | 76.0 ± 7.7 | 76.7 ± 7.6 |
| Sex: Female, Male(Participants) | On the Move | On the Move - Delayed | Total |
|---|---|---|---|
| Female | 224 | 218 | 442 |
| Male | 48 | 39 | 87 |
| Race (NIH/OMB)(Participants) | On the Move | On the Move - Delayed | Total |
|---|---|---|---|
| American Indian or Alaska Native | 0 | 1 | 1 |
| Asian | 1 | 1 | 2 |
| Native Hawaiian or Other Pacific Islander | 1 | 0 | 1 |
| Black or African American | 8 | 41 | 49 |
| White | 258 | 206 | 464 |
| More than one race | 2 | 6 | 8 |
| Unknown or Not Reported | 2 | 2 | 4 |
| Ethnicity (NIH/OMB)(Participants) | On the Move | On the Move - Delayed | Total |
|---|---|---|---|
| Hispanic or Latino | 2 | 3 | 5 |
| Not Hispanic or Latino | 259 | 238 | 497 |
| Unknown or Not Reported | 11 | 16 | 27 |
| Duke Comorbidity index(units on a scale) | On the Move | On the Move - Delayed | Total |
|---|---|---|---|
| Mean | 2.9 ± 1.3 | 2.8 ± 1.2 | 2.8 ± 1.3 |
| Fear of falling(Participants) | On the Move | On the Move - Delayed | Total |
|---|---|---|---|
| Count of participants | 129 | 124 | 253 |
| Fall prior year(Participants) | On the Move | On the Move - Delayed | Total |
|---|---|---|---|
| Count of participants | 84 | 78 | 162 |
| Gait speed(m/s) | On the Move | On the Move - Delayed | Total |
|---|---|---|---|
| Mean | 0.99 ± 0.24 | 0.96 ± 0.25 | 0.98 ± 0.24 |
2 further baseline measures are reported on the registry.
PDFs hosted by the registry, ClinicalTrials.gov.
Plan to share: Yes — All collected individual participant data may be shared. Because the human subjects included in the project could potentially be identified, given the relatively limited geographic distribution of these subjects, investigators requesting data will be required to sign a data sharing agreement. For external requests, the agreement will be executed through the University's Office of Research; and for internal requests, through email.
Supporting information: Study protocol, Statistical analysis plan, Informed consent form
Time frame: Data sets will be available at the time the primary paper is accepted for publication or at 2 years after the last participant is followed whichever comes first.
Access criteria: Data will be available by secure transfer to investigators who complete a data sharing agreement for data from this project. The sharable data will be archived at the study's home site and will be available for sharing by submitting a request to the PI. Once a request is approved by the PI and the requester agrees to the conditions for data use, the data will be transferred.
Ran from Jun 2022 to primary completion in Sep 2025, 38 months.
Results were first posted in Nov 2026, 1 year 2 months after primary completion.
Of 201 non-industry interventional studies with no phase under Mobility Limitation, half reached primary completion within 17 months of starting (the median), counting those still running; a quarter within 7 and three quarters within 42. This study's 38 months is above that.
Counting every sponsor, half of 206 studies reached it within 17 months; a quarter within 7 and three quarters within 42.
How these figures are worked out, and which studies are left out of them.
From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗
This study is completed, as verified in Oct 2026. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.